A large new study published in Nature Medicine has found that aggressively lowering blood pressure cut dementia risk by 15% over four years — and the evidence suggests the benefit compounds substantially the earlier intervention begins. High blood pressure is one of the most significant modifiable risk factors for dementia, yet the blood pressure levels once considered safe by conventional standards may still be doing measurable harm to the brain over decades. This article examines that new study, reviews what current research identifies as the optimal blood pressure target, and outlines the lifestyle strategies with the strongest evidence for reaching it.
Table of Contents
The New Study
This study, published recently in Nature Medicine, involved a large research effort carried out in China. Scientists identified about 34,000 people living in rural villages who were over 40 and had high blood pressure. They were divided into two groups. One group received regular care from their doctors. The intervention group was placed on medications targeting a blood pressure of less than 130. The researchers aimed to determine how an aggressive approach to blood pressure control would affect rates of dementia [1].
The connection between blood pressure and dementia is well established in clinical research. Blood pressure is one of the most significant — and most modifiable — risk factors for dementia.
The brain requires a large volume of blood to supply energy and oxygen. It is filled with blood vessels, many of which are tiny and sensitive. Elevated blood pressure puts stress on the whole system, producing several compounding problems.
It damages blood vessels, increases inflammation, and generates oxidative stress, which accelerates neuron aging. As the body responds to this damage over time, vessels become stiffer and can form plaques — worsening the problem further. With age, the brain loses the ability to adjust to higher pressure and repair accumulated damage.
This cumulative vascular damage to the brain is a recognised root cause of dementia. Critically, the process is often silent for years — there are no symptoms until substantial damage has accumulated. By the time cognitive changes become noticeable, the underlying injury may have been building for a decade or more. This is why studies examining blood pressure and dementia risk often focus on midlife readings: the brain changes do not happen immediately, but a long window of elevated pressure produces damage that compounds over time.
It therefore makes direct sense to examine whether lowering blood pressure can also reduce dementia risk — and what the optimal blood pressure target looks like for the brain.
Here is what the researchers found. At the end of four years, average blood pressure had fallen by about 30 points in the intervention group, compared to a fall of just 8 points in the control group [1].
The intervention group met the target of under 130. The crucial question: did this translate into lower dementia rates?
It did. The intervention group had a 15% lower risk of dementia than the control group [1].
That is a clinically meaningful result — achieved over only four years. Because damage from high blood pressure is cumulative and builds slowly over decades, sustained blood pressure control over a longer period is likely to produce substantially greater protection.
The Right BP Target
The study used a blood pressure target of 130. Getting below it clearly helped — but does 130 represent the optimal level? How low should blood pressure be?
Two major studies have substantially changed the evidence-based answer to this question. For a long time, medical guidance treated a systolic blood pressure — the top number on a reading — up to 140 as acceptable. The view was that while 120/80 was ideal, 140 was still within a reasonable range. That view has now been revised by the data.
Part of the reason doctors previously accepted 140 was that blood pressure tends to rise with age, so a modestly higher reading was treated as a normal part of aging. Newer research demonstrates that even this modest elevation causes meaningful harm.
The first major challenge to the old standard came from the SPRINT study — the Systolic Blood Pressure Intervention Trial — which enrolled over 9,000 participants. The study compared two groups: one targeting systolic blood pressure below 140, the other targeting below 120. Participants were at high risk for heart disease but did not have diabetes or a prior stroke.
The results were so decisive that the study had to be stopped early. After just 3.3 years — against a planned 4–6 year timeline — it was already clear that the lower target produced substantially better outcomes. There was a 27% lower risk of heart attack, stroke, or cardiovascular death in the below-120 group [2].
For all-cause mortality specifically, there was a 25% lower risk of dying in the group targeting below 120 [3].
A 25% reduction in overall mortality from a blood pressure target change is a substantial finding — one that has reshaped clinical thinking.
A subsequent study in China then tested these results in a larger and more diverse population: over 11,000 people, this time including those with diabetes and those who had already experienced a stroke — populations excluded from SPRINT.
The findings were consistent. Lowering systolic blood pressure to less than 120 reduced the risk of heart attacks, strokes, and cardiovascular death by 12% [4].
It also cut the overall risk of death from any cause by 21% over three and a half years [5].
The combined message from these trials is consistent: the old standard of 140 is insufficient. Even the 130 target used in the dementia study above — while clearly beneficial — falls short of the evidence-based optimal. The data point toward a systolic target below 120 for meaningful long-term protection.
But what about the brain specifically? Does the same lower target also protect against dementia?
A follow-up analysis of the SPRINT study population examined this question directly. The pattern matched what was found for cardiovascular outcomes: participants assigned to the lower blood pressure target — below 120 — had a 14% lower chance of developing dementia during the follow-up period [6].
A separate study adds further evidence in the same direction. It found that middle-aged women with a systolic blood pressure between 120 and 139 showed increased markers of cognitive decline a decade later. This was not yet clinical dementia, but it indicated that measurable brain changes were accumulating at levels previously considered acceptable. The researchers concluded that reducing blood pressure below 120 is associated with a meaningfully lower risk of cognitive decline [7].
Taken together, this body of evidence supports a consistent conclusion: a systolic blood pressure below 120 is the right target — not just for cardiovascular protection, but for long-term brain health as well.
How to Lower
The evidence points clearly toward blood pressure below 120 as the meaningful protective target. Here are five of the most well-supported strategies for reaching and maintaining it.
1. Reduce sodium intake. The American Heart Association recommends no more than 1,500 milligrams of sodium per day — roughly half a teaspoon of salt. The average American currently consumes around 3,500 milligrams daily, more than double that amount.
A meta-analysis of 85 different trials identified a consistent dose-response relationship: as sodium intake rises, blood pressure rises with it [8].
The mechanism is straightforward. Sodium causes the body to retain water, increasing blood volume. Greater fluid in the blood vessels raises the pressure within them — similar to the way a balloon becomes increasingly tense as more air is added.
Salt substitutes are a practical option for many people. These products replace some of the sodium chloride in regular salt with potassium chloride, delivering both a sodium reduction and a potassium increase in a single dietary change. A large study in China found that making this simple switch was associated with a 12% reduction in strokes and a lower overall death rate over the study period [9].
2. Adopt a blood-pressure-focused dietary pattern. Researchers have developed an evidence-based dietary framework specifically for blood pressure management: the DASH diet — Dietary Approaches to Stop Hypertension. One analysis examining multiple types of blood pressure interventions concluded that the DASH diet may be the most effective non-medication strategy for lowering blood pressure [10].
The DASH pattern is straightforward: emphasise vegetables, fruits, low-fat dairy, whole grains, lean proteins such as chicken and fish, and nuts, while minimising sweets, sugary drinks, and high-fat meats. The pattern is high in fibre, high in lean protein, and nutritionally dense.
One notable benefit of the DASH diet is that it naturally raises potassium intake through foods such as spinach, bananas, peas, and beans. Potassium plays a direct role in blood pressure regulation: it helps balance sodium levels and encourages the walls of blood vessels to relax, reducing vascular resistance and lowering pressure. The sodium-reducing and potassium-raising effects of the DASH diet work in combination — which is part of why it outperforms simple salt restriction as a standalone strategy.
From the MicroVitamin range
MicroVitamin includes potassium (99 mg as potassium chloride), formulated to complement dietary sources of this mineral within an evidence-informed multivitamin. MicroVitamin.
3. Add regular exercise. Physical activity is one of the most reliably effective interventions for blood pressure. Both aerobic exercise — such as walking, cycling, or swimming — and resistance training have been shown to reduce systolic blood pressure in clinical studies. The benefits are dose-responsive: more activity generally produces greater reductions, though even modest increases from a sedentary baseline generate measurable improvement.
Getting started with exercise can feel challenging, particularly for those who have been relatively inactive. The good news is that small changes produce real physiological benefits — there is no need to reach a high volume immediately to begin seeing results.
For those who find it difficult to set aside a long exercise block, a practical approach is exercise snacking — short bursts of physical activity distributed across the day rather than concentrated into a single session. Instead of carving out a dedicated 30-minute block, a few sets of wall squats between meetings, a brisk walk at lunch, or stair climbing in place of lifts can accumulate into significant cardiovascular benefit. Research supports that brief bouts are physiologically effective even when they are not consecutive, and that distributing activity throughout the day can produce blood pressure reductions comparable to a single longer session.
4. Address excess body weight. For individuals who are overweight, weight loss is a powerful lever for blood pressure control. Research shows a clear dose-response relationship: the greater the weight loss, the greater the reduction in blood pressure [11].
The dietary and activity changes outlined above will support weight management alongside blood pressure control. For those whose weight remains above a healthy range despite consistent lifestyle effort, medications such as GLP-1 receptor agonists may be a clinically appropriate addition in consultation with a healthcare provider. Medication in this context is a complement to lifestyle, not a substitute for it.
5. Consider blood pressure medication where indicated. For individuals whose lifestyle factors are well-managed — diet, sodium intake, activity level, and weight are all addressed — but whose blood pressure still exceeds 120 systolic, a clinical discussion about antihypertensive medication is appropriate. The evidence supports medication as an addition to lifestyle modification, not a replacement for it. Different classes of blood pressure medications work through distinct mechanisms — some reduce fluid volume, others relax blood vessel walls, others reduce the force of the heartbeat — and the right choice depends on individual circumstances including other health conditions. This is a conversation to have with a healthcare provider who can assess the full clinical picture. What the research makes clear is that the benefits of reaching below 120 are substantial and real, and medication is a legitimate and well-evidenced tool for getting there when lifestyle alone is insufficient.
References
1. https://www.nature.com/articles/s41591-025-03616-8
2. https://www.nejm.org/doi/10.1056/NEJMoa1901281
3. https://www.nejm.org/doi/10.1056/NEJMoa1901281
4. https://pubmed.ncbi.nlm.nih.gov/38945140/
5. https://pubmed.ncbi.nlm.nih.gov/38945140/
6. https://www.neurology.org/doi/abs/10.1212/WNL.0000000000213334
7. https://pubmed.ncbi.nlm.nih.gov/25814553/
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055199/
9. https://jamanetwork.com/journals/jamacardiology/article-abstract/2829790
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC7792371/
11. https://www.uptodate.com/contents/image?imageKey=NEPH%2F60178&topicKey=PC%2F3852&source=see_link
